feedback

Course Director

Paul M. Ridker, MD, MPH, FACC, FAHA
Paul M. Ridker, MD, MPH, FACC, FAHA

Harvard Medical School
Brigham and Women’s Hospital
Boston, Massachusetts

Faculty

Brendan M. Everett
Brendan M. Everett, MD, MPH, FACC, FAHA

Harvard Medical School
Brigham and Women's Hospital
Boston, Massachusetts

Prof. Wolfgang Koenig
Prof. Wolfgang Koenig, MD, FRCP, FESC, FACC, FAHA

German Heart Center Munich
Technical University of Munich
Munich, Germany

Accredited by

Penn State College of Medicine / Medical Learning Institute, Inc.

Activity Details

Credit Types:CME / CE
Credit Amount:1.5 Credits
Release Date:2018-Dec-12
Expiration Date:2019-Dec-11
Estimated Time for Completion:90 minutes
Registration Required:No
Cost:Free of charge

Activity Description and Educational Objectives

In this activity, based on a recent live symposium held in Chicago, Illinois, cardiovascular disease experts discuss the relationship between inflammation and the development of atherosclerosis, the efficacy and safety of current and emerging therapy targeting inflammation for the secondary prevention of cardiovascular events, and the application of recommendations for the use of inflammatory biomarkers to assess cardiovascular risk. The expert panel also provides guidance on data surrounding anti-inflammatory agents and their potential placement within treatment plans for patients with cardiovascular disease.

Upon completion of this activity, participants will be able to:

  • Identify the relationship between inflammation and the pathogenesis of cardiovascular disease (CVD)
  • Implement consensus recommendations for the use of inflammatory biomarkers to assess CVD risk
  • Assess the benefits and limitations of statin therapy, including the anti-inflammatory properties for secondary prevention of CVD risk
  • Recognize the efficacy and safety of current and emerging therapy targeting inflammation for the secondary prevention of CVD risk

Target Audience

This activity has been designed to meet the educational needs of cardiologists, nurses, and other clinicians involved in the management of cardiovascular disease.

Nursing Education Purpose Statement

The purpose of this activity is to improve knowledge and competence of nurses concerning the management of patients with cardiovascular disease.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. A score of 80% or higher is needed to obtain CME credit and 70% or higher to obtain CE credit. There are no pre-requisites and there is no fee to participate in this activity or to receive CME/CE credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Enduring Material
Release and Expiration Dates: December 12, 2018 - December 11, 2019
Time to Complete: 90 minutes

Faculty and Disclosure / Conflict of Interest Policy

Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by Penn State College of Medicine and Medical Learning Institute, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Course Director and Moderator

Paul M. Ridker, MD, MPH, FACC, FAHA
Eugene Braunwald Professor of Medicine
Harvard Medical School
Director, Center for Cardiovascular Disease Prevention
Brigham and Women’s Hospital
Boston, Massachusetts

Paul M. Ridker, MD, MPH, FACC, FAHA, has a financial interest/relationship or affiliation in the form of:
Grant/Research Support from Donald W. Reynolds Foundation; Doris Duke Charitable Foundation; James and Poly Annenberg La Vea Charitable Trusts; National Heart, Lung, and Blood Institute; The American Heart Association; The Leducq Foundation; The National Cancer Institute. Dr. Ridker receives investigator-initiated research support from AstraZeneca; Novartis Pharmaceuticals, Inc.; Kowa Pharmaceuticals, Inc.; and Pfizer, Inc.; as well as non-financial research support from Amgen, Inc.
Other Financial or Material Support Dr. Ridker is listed as a co-inventor on patents held by the Brigham and Women's Hospital that relate to the use of inflammatory biomarkers in cardiovascular disease that have been licensed to AstraZeneca and Siemens. Dr. Ridker has served during the past year as a research consultant to Corvidia; Eisai; Inflazome; Janssen Pharmaceuticals, Inc.; Novartis Pharmaceuticals, Inc.; Quintiles Pharmaceuticals (IQVIA); and sanofi-aventis.

Paul Ridker, MD, MPH, FACC, FAHA, does intend to discuss either non-FDA-approved or investigational use for the following products/devices: canakinumab and methotrexate.

Faculty

Brendan M. Everett, MD, MPH, FACC, FAHA
Assistant Professor of Medicine
Harvard Medical School
Director, General Cardiology Inpatient Service
Brigham and Women's Hospital
Boston, Massachusetts

Brendan M. Everett, MD, MPH, FACC, FAHA, has a financial interest/relationship or affiliation in the form of:
Consultant for Amgen, Inc.
Grant/Research Support from Novartis Pharmaceuticals, Inc.; and Kowa Pharmaceuticals, Inc.
Advisory Board for Roche Diagnostics.
Other Financial or Material Support Spouse receives a writing fee for the Merck Manual.

Brendan M. Everett, MD, MPH, FACC, FAHA, does not intend to discuss any non-FDA-approved or investigational use of any products/devices.

Prof. Wolfgang Koenig, MD, FRCP, FESC, FACC, FAHA
Clinic for Cardiovascular Diseases
German Heart Center Munich
Technical University of Munich
Munich, Germany

Prof. Wolfgang Koenig, MD, FRCP, FESC, FACC, FAHA, has a financial interest/relationship or affiliation in the form of:
Consultant for Amgen Inc.; AstraZeneca; DalCor Pharmaceuticals; Kowa Pharmaceuticals, Inc.; Novartis; Pfizer, Inc.; The Medicines Company.
Grant/Research Support from Abbott; Beckmann; Roche Diagnostics; and Singulex.
Other Financial or Material Support from AstraZeneca and sanofi-aventis for honoraria from lectures.

Prof. Wolfgang Koenig, MD, FRCP, FESC, FACC, FAHA, does not intend to discuss any non-FDA-approved or investigational use of any products/devices.

Nurse Reviewer

Janice Trainor-Tellier, MSN, RN

Janice Trainor-Tellier, MSN, RN, has no financial interests/relationships or affiliations in relation to this activity.

Medical Director

Chris Washburn, PhD
PVI, PeerView Institute for Medical Education

Chris Washburn, PhD, has no financial interests/relationships or affiliations in relation to this activity.

Other PVI staff who may potentially review content for this activity have disclosed no relevant financial relationships.

Penn State College of Medicine staff and faculty involved in the development and review of this activity have disclosed no relevant financial relationships.

The associates of Medical Learning Institute, Inc. do not have any financial relationships or relationships to products or devices with any commercial interest.

Disclaimer

The information provided at this CME/CE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. Recommendations for the use of particular therapeutic agents are based on the best available scientific evidence and current clinical guidelines. No bias towards or promotion for any agent discussed in this program should be inferred.

Providership, Credit, and Support

Physicians

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Penn State College of Medicine and PVI, PeerView Institute for Medical Education. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Penn State College of Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Information about CME credit for this activity is available by contacting Penn State at 717-531-6483 or ContinuingEd@hmc.psu.edu. Reference course # G6355-19-T.

Nurses

Medical Learning Institute, Inc.
Provider approved by the California Board of Registered Nursing, Provider Number 15106, for 1.5 contact hour(s).

Providership


This CME/CE activity is jointly provided by Penn State College of Medicine and PVI, PeerView Institute for Medical Education; this activity is also co-provided by Medical Learning Institute, Inc.

Support

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports. For approved prescribing information, please consult the manufacturer’s product labeling.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView or any of its partners, providers, and/or supporters.

About This CME/CE Activity

PVI, PeerView Institute for Medical Education, Penn State College of Medicine, and Medical Learning Institute, Inc. are responsible for the selection of this activity's topics, the preparation of editorial content, and the distribution of this activity. The preparation of PeerView activities is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of PVI, Penn State College of Medicine, and Medical Learning Institute, Inc. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. For approved prescribing information, please consult the manufacturer's product labeling. No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our activities. No responsibility is taken for errors or omissions in activities.

Copyright © 2000-2018, PeerView

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.